In consultation with Dr. William Rayburn, Dr. Muller has put together an issue designed to educate the reader on the rapid
progress in Gynecologic Cancer Care. More than any other field in obstetrics and gynecology, gynecologic oncology has seen
an explosion in integrated drug development and technology, including personalized medicine, germline and somatic testing,
targeted therapeutics, biologic and immunotherapies, improved robotic technology, and a paradigm shift towards "less is more."
Evolving data in quality measures including enhanced surgical recovery, integrative palliative care, and survivorship management
has strengthened the need for a seemless team approach to the care of our patients. Despite the complexity and rapid discoveries
leading to significant change in practice, the dedication to patients is the driver to stay up to date and participate in
the research and clinical trials that lead to the cancer care advances that are substantial in this update. Expert authors
have contributed articles on the following topics: Trends in Gynecologic Cancer Care in North America: Safety, Value and Quality;
Cancer Screening and Prevention Highlights in Gynecologic Cancer; Germline and Somatic Tumor Testing in Gynecologic Cancer
Care; Less is More: Minimally Invasive and Quality Surgical Management of Gynecologic Cancer; Ovarian Cancer: Clinical Trial
Breakthroughs and Impact on Management; Endometrial Cancer: Obesity, Genetics and Targeted Trials; Cervical Cancer: A Global
and Access to Care Crisis; Vulvar and Vaginal Cancer; Gestational Trophoblastic Neoplasia; Chemotherapy, Biologic and Immunotherapy
Breakthroughs in Cancer Care; Palliative Care in Gynecologic Oncology; Personalized Medicine in Gynecologic Cancer: Fact or
Fiction; and Survivorship Care in Gynecologic Cancer.